1. Introduction {#s0005}
===============

Bipolar disorder (BD) affects up to 3% of the adult population, and is a leading cause of functional impairment, morbidity and suicide ([@bb0005]). BD manifests clinically as a recurrent cycling between the emotional elevations of manic episodes and the dysphoria of depressive episodes, with intervening periods of euthymia, a mood state in which the range of emotions is neither depressed nor highly elevated. People with BD may also exhibit cognitive deficits, including impairments in attention, executive function, response inhibition, and short-term memory ([@bb0015; @bb0010]).

Histological studies show that BD is associated with a downregulation of key oligodendrocyte-related and myelin-related genes and their transcription factors, which are critical for axonal myelination and connectivity ([@bb0020]). Technological advances in neuroimaging techniques allow the investigation of white matter (WM) structure *in vivo*. While standard structural MRI provides limited contrast in the brain\'s WM, diffusion tensor imaging (DTI), a variant of MRI which measures water diffusion in living brain tissues ([@bb0025]) is uniquely sensitive to WM microstructure, including axonal coherence, fiber density, and myelin integrity. One common measure of WM microstructure is fractional anisotropy (FA), an indirect scalar measure of the coordinated directionality and coherence of fibers within a WM bundle ([@bb0025; @bb0030]). Decreases in FA have been detected in disorders of central nervous system myelination ([@bb0035; @bb0030]), suggesting that it is a measure sensitive to myelination anomalies. Lower FA can also indicate a reduction in the density of WM fibers, a loss in axonal bundle coherence (loss of structural organization), or a variation in membrane permeability to water ([@bb0040]). Also commonly included in WM assessments are radial diffusivity (RD), a measure of diffusion perpendicular to the axonal fibers, and mean diffusivity (MD), the average of the principal diffusivities in three diffusion directions, and an overall evaluation of the molecular motion in a voxel or region, characterizing the overall presence of obstacles to diffusion ([@bb0045]). MD and RD, which are unaffected by the loss of bundle coherence, often increase when myelin is damaged or fails to develop normally ([@bb0050; @bb0055; @bb0045]). A diffusivity-associated myelin reduction is consistent with *post mortem* studies that show an apparent loss of glia in patients with mood disorders ([@bb0060; @bb0065]), and a gene-expression study ([@bb0020]) in which bipolar brains showed a reduced expression of key oligodendrocyte and myelination genes.

Despite growing interest in impaired WM connectivity in BD, the DTI findings across studies have been inconsistent ([@bb0070]). Reports have found lower ([@bb0080; @bb0075; @bb0085; @bb0090; @bb0095; @bb0100; @bb0105; @bb0110; @bb0115; @bb0120; @bb0125; @bb0180; @bb0185; @bb0130; @bb0135; @bb0140; @bb0145; @bb0150; @bb0155; @bb0160; @bb0165; @bb0175; @bb0170]), higher ([@bb0190; @bb0200; @bb0195]), or no difference ([@bb0205; @bb0210]) in FA between patients with BD and healthy volunteers. The most consistent findings have been of decreased FA and/or increased MD in limbic-striatal, callosal and prefrontal regions in adults ([@bb0080; @bb0090; @bb0205; @bb0095; @bb0100; @bb0105; @bb0110; @bb0125; @bb0135; @bb0140; @bb0145; @bb0160; @bb0165; @bb0215; @bb0220; @bb0170]), children ([@bb0115; @bb0120; @bb0185]) and adolescents ([@bb0075; @bb0085; @bb0130; @bb0150; @bb0155]) with BD. Such heterogeneity in findings may reflect DTI data acquisition differences and differences in patient samples, as well as the effects of lithium and mood state, which were not controlled for in many of these studies.

To better map the profile of these anomalies, we used a whole brain voxel-based analysis rather than TBSS ([@bb0505]). TBSS does pre-select voxels with high signal to noise ratio (SNR) (for FA) and these tend to be among the ones that show disease effects, as voxels with lower mean FA also tend to have lower SNR and disease effects are harder to detect. Even so, a great deal of the scan is discarded if one focuses only on the white matter skeleton (which is analyzed in TBSS). Since TBSS greatly reduces the data available and since we wanted to be sensitive to effects throughout the 3D extent of WM structures; throughout the imaged anatomy, we chose to use voxel-based analysis, as it allows for a more comprehensive survey. We realize this is a trade-off, in that the non-skeleton voxels actually deplete power if there is no disease effect there, as they cause a heavier multiple comparisons correction. But, in this case, there were effects throughout the WM and not on the skeleton, that TBSS would have missed. We also wanted to avoid the limitations of region of interest (ROI) based methods, which may focus on a limited number of structures. Whole brain statistical maps reveal spatial patterns of WM abnormalities occurring throughout the brain, and are well suited to studying psychiatric disease, where the location of neural abnormalities may not be known *a priori*.

An advantageous aspect of our study is that at scan time, all our patients were euthymic, and no patients were treated with lithium. This avoids the confounding effects of lithium on brain measures, which have been documented in studies of cortical thickness and subcortical gray matter volumes in BD patients ([@bb0245; @bb0235; @bb0240; @bb0230; @bb0225]). Indeed, lithium-treated HIV-positive patients show diffusely increased FA and decreased MD ([@bb0250]), compared to lithium-free patients. Similarly, lithium-treated bipolar patients show higher FA in the WM tracts connecting the amygdala with the subgenual cingulate cortex than do BD individuals who are not treated with this medication ([@bb0090]). Additionally, due to prior reports of mood state effects on amygdala ([@bb0255]) and orbitofrontal cortex (OFC) gray matter volumes ([@bb0260]), as well as on other cortical and subcortical brain areas ([@bb0265; @bb0245]), and given that the impact of mood state on WM integrity is not yet understood, to avoid any confounding effects of mood state, we also took special precautions to control for mood state effects by sampling exclusively from euthymic individuals in our patient sample.

2. Materials and methods {#s0010}
========================

2.1. Participants {#s0015}
-----------------

Individuals with bipolar I disorder were recruited by the UCLA Mood Disorders Clinic, the Bipolar Disorders Clinic of the Veterans Affairs Greater Los Angeles Health Care System, and via newspaper advertising. Control subjects were recruited by advertisement in local newspapers and campus flyers. Patients and controls were both evaluated using the Structured Clinical Interview for DSM-IV (SCID) to confirm current mood state and an accurate diagnosis of BD or the absence thereof. Bipolar subjects with other active Axis I co-morbidities were excluded. Subjects were also excluded if they were taking lithium as a medication. Patients were considered lithium-free if they had not taken lithium medication for at least 1 month prior to the scan. Additional exclusion criteria included current manic or depressed mood state at scan time. Mood was assessed using the SCID, in combination with the Young Mania Rating Scale (YMRS; ([@bb0270])), and the 21-item Hamilton Depression Rating Scale (HAMD; ([@bb0275])). A score of \< 7 on the YMRS and HAM-D were required for patients included in the study. Information on patients\' prior course of illness and prior and current medication use was obtained by self-report, from medical records when available, and by corroboration of family members or partners when available and permitted by patients. The study protocol was approved by the Institutional Review Board at UCLA and the VA Greater Los Angeles Healthcare System. Each participant provided written informed consent.

Healthy controls were excluded if they met SCID criteria for any current or past psychiatric diagnosis (including history of substance abuse or dependence) or were currently taking psychotropic medications. Additional exclusion criteria for all subjects included left-handedness, hypertension, neurological illness, metal implants, or a history of skull fracture or head trauma with loss of consciousness of more than 5 min.

2.2. Brain image acquisition {#s0020}
----------------------------

For all scans, the subject was scanned on a Siemens 1.5 T Sonata MRI scanner. Whole-brain T1-weighted structural images were acquired using a 3D magnetization-prepared rapid gradient echo (MP-RAGE) sequence (160 1-mm thick sagittal slices with a 256 × 256 acquisition matrix; field of view, 256 mm; TI/TR/TE = 1100/1900/4.38 ms; flip angle, 15°; scan time, 8.1 min). Diffusion-weighted images (DWIs) were acquired parallel to the anterior--posterior (AC--PC) commissural line using the following acquisition parameters: 55 2.5 mm thick axial slices (no gap); field of view, 240 mm, TR/TE = 6400/83 ms, with a 96 × 96 acquisition matrix, scan time: 3.9 min. Thirty-five DWIs were acquired per subject: 5 with no diffusion sensitization (i.e., T2-weighted b~0~ images) and 30 non-collinear DWIs (*b* = 1000 s/mm^2^) with gradient directions evenly distributed on the hemisphere.

2.3. Preprocessing {#s0025}
------------------

Images were visually inspected for artifacts that could interfere with image processing and analysis, and those that were not considered acceptable were excluded from the study. Extracerebral tissues were removed from each subject\'s T1-weighted MRI scan by manual editing. These whole-brain masks were also used to remove extracortical tissue from the DWIs after aligning the T1-weighted structural data to the non-diffusion weighted (b~0~) images via a rigid-body transform. All skull-stripped anatomical scans were aligned to a high-resolution single-subject average brain MRI scan, the Colin27 brain template ([@bb0280]), in the ICBM standard stereotaxic space ([@bb0285]) using a 9-parameter registration (allowing global scaling) via the FSL/FMRIB linear image registration tool (FLIRT) algorithm with default trilinear interpolation ([@bb0290]).

Raw DWIs were corrected for eddy-current induced distortions using eddy_correct, from the FSL software package ([@bb0295]) and registered to standard space by elastically aligning subjects\' averaged b~0~ images to their Colin27 aligned T1-weighted MP-RAGE structural scan using a mutual information cost function ([@bb0300]) to account for EPI (echo planar imaging) induced distortions and susceptibility artifacts. Diffusion tensors were then computed from the 35-gradient diffusion weighted images using the FSL software\'s DTIFIT tool ([@bb0295]). Scalar maps of FA, RD and MD were computed for each subject from the resulting tensor eigenvalues (λ~1~, λ~2~, λ~3~) at each voxel ([@bb0305]). To improve inter-subject registration, and improve the power to detect group differences by reducing the macroscopic misregistration of WM, an FA-based minimal deformation template (MDT) image was used ([@bb0310]). To do this, all individual FA maps were non-linearly registered to the affine average template using non-linear inverse-consistent elastic intensity-based registration ([@bb0315]). The non-linear average template was computed as a voxel-wise average of the intensities of the FA maps that had been non-linearly registered to the affine average template. Finally, we created the MDT by applying inverse geometric centering of the displacement fields to the non-linear average ([@bb0320]). [@bb0310] showed that using an MDT made in this way, versus an ICBM atlas or a single optimally chosen subject, leads to improved registration accuracy. To further ensure alignment of white matter tracts, FA maps were thresholded to include only regions where FA \> 0.25 and re-registered to the thresholded MDT. The deformation fields from the second round of registration were then applied to the full FA map for each individual to avoid any missing data. Once the images were aligned they were then smoothed with a Gaussian filter with an 8 mm full-width-half-maximum (FWHM), to reduce noise and improve the sensitivity of group comparisons. The FA-based registrations were applied to the MD and RD maps to align them to the common template.

2.4. Statistical analyses {#s0030}
-------------------------

A general linear model was fitted at each voxel of the registered FA, MD and RD maps to identify WM regions showing a significant main effect of diagnosis. This model included age and sex as covariates. Sex differences were tested but were not significant for any map, and so, sex was dropped from the model. Supplementary analyses were performed adding HAM-D scores and educational level as additional covariates since many studies have shown higher educational levels may be neuroprotective ([@bb0325; @bb0330]) and since we controlled for the effects of mood state by recruiting only euthymic bipolar individuals. As these supplementary analyses found that both educational level and HAM-D scores were significant predictors of WM integrity, and because educational level was not collinear with age (*r* = 0.098, *p* = 0.54), the final model that was fit at each WM voxel included diagnosis, age, HAM-D, and educational level.

The anatomic location of each resulting significance cluster was determined with the help of a DTI WM fiber atlas ([@bb0335]). Since our voxel-wise approach involves running thousands of statistical tests (i.e., tests at many points in the brain), we controlled for false positives using the searchlight false discovery rate method (sFDR; ([@bb0340])). All statistical maps in this study were thresholded at the appropriate corrected *p*-value of 0.05 after performing sFDR to show only regions of significance; uncorrected *p*-values are then shown only within these regions.

*Post hoc* exploratory analyses were performed to assess any relationships between diffusion characteristics (FA, MD, RD) and clinical measures in the patients, including psychotropic medication at scanning, history of psychosis, and duration of illness as a proportion of the patient\'s lifetime (*R* = 0.44 with age), where the start of illness was defined as the time of the first treatment. Psychotropic medication and history of psychosis were analyzed as yes/no variables. In addition, although all of our patients were lithium-free at scan time, seven had previous lithium exposure. For this reason, we also compared WM structure between previously exposed patients to those who were lithium naïve.

3. Results {#s0035}
==========

3.1. Participants {#s0040}
-----------------

34 euthymic subjects with BP I disorder (11f; 37.4 ± 12.0 years.) and 29 age- and sex-matched healthy control subjects (12f; 37.5 ± 13.3 years.) were initially scanned. 9 bipolar and 10 control subjects were excluded after visually assessing the DTI data, due to artifacts and signal dropouts; 2 bipolar subjects were excluded due to poor registration results in one subject and a lack of complete demographic information for the other subject. A total of 23 euthymic subjects with BP I disorder (7 women; mean age: 36.0 ± 12.5 SD years) and 19 age- and sex-matched healthy control subjects (6 women; mean age: 36.2 ± 12.4 SD years) were included in the analysis. Diagnostic groups did not differ in mean age (*t* = 0.03; *p* = 0.98), sex distribution (χ^2^ = 0.006; *p* = 0.94), or educational level (*t* = 1.76; *p* = 0.09).

Clinical information on bipolar subjects is presented in [Table 1](#t0005){ref-type="table"}. Patients had a mean YMRS score of 1.7 ± 2.2 and a mean HAM-D score of 4.7 ± 2.2 on the day of the scan, and had been ill for 18.7 ± 12.1 years, on average. Seven of the 23 bipolar subjects (30.4%) were not on medications at the time of scanning. The remaining 16 subjects (69.6%) were currently taking one or more medications, including valproic acid (n = 4), lamotrigine (n = 4), aripiprazole (n = 10), olanzapine (n = 2), quetiapine (n = 3), paroxetine (n = 1), fluoxetine (n = 2), escitalopram (n = 1), bupropion (n = 3), oxcarbazepine (n = 1), trazodone (n = 1), citalopram (n = 1), and dextramphetamine--amphetamine (n = 1). Control subjects were not on medications at the time of scanning.

Within the bipolar cohort, 12 subjects (52%) had a history of alcohol abuse or dependence, 8 subjects (35%) reported marijuana abuse or dependence, and 7 subjects (30%) reported cocaine abuse or dependence. There was also 1 case (4%) of opioid dependence, 4 (17%) of stimulant dependence, and 2 (9%) cases of abuse or dependence on another illicit substance. There was no history of hallucinogen abuse or dependence. Altogether, 7 (30%) subjects were not abusing or depending on illicit substances and 16 (70%) were. All patients needed to be substance free for six months or more to be enrolled in the study. None of the controls had abused or were dependent on illicit substances, as these were part of the exclusion criteria.

3.2. White matter {#s0045}
-----------------

Compared to healthy individuals, the BD group had significantly lower FA in the corpus callosum (CC), as well as bilaterally in the inferior longitudinal and inferior fronto-occipital fasciculus (ILF and IFOF), the superior longitudinal fasciculus (SLF), and *tapetum* ([Fig. 1](#f0005){ref-type="fig"}). Axial sections also revealed FA deficits in patients in the anterior callosal *genu*. No significant FA differences were detected in the superior fronto-occipital fasciculus (SFOF). Within the limbic association fibers, the BD group showed lower FA in the left cingulum pertaining to the hippocampus, bilaterally in the fornix, and in a region including the right *stria terminalis* (ST). Within the projection fibers, patients had lower FA bilaterally in the posterior thalamic radiation (PTR) and the posterior *corona radiata* (PCR), along with the right anterior and superior *corona radiata* (ACR and SCR), and the left cerebral peduncle. No significant FA differences were detected in the internal capsule.

Maps of group difference in FA showed patterns similar to the radial and mean diffusivity maps. As predicted, RD and MD values were higher in bipolar patients than controls, with stronger effect sizes for RD and slightly weaker effect sizes for MD ([Figs. 2, 3](#f0010 f0015){ref-type="fig"}). In contrast to the FA maps, the *genu* did not show a significant group difference in diffusivity maps, while the bilateral SFOF demonstrated both higher RD and MD. Other dissimilarities between FA and RD/MD maps included a lack of detectable MD differences between groups in the *tapetum* or the *corona radiata*, an RD increase in the bilateral SCR and right PCR, a bilateral increase of MD and RD in the hippocampus, ST region, the anterior and posterior limbs of the internal capsule (ALIC and PLIC, respectively), a right-only increase in the retrolenticular limb of the internal capsule (RLIC), and no diffusivity differences in the ACR and cerebral peduncle. No regions with significantly higher FA or lower MD or RD were found in patients as compared to healthy controls. [Table 2](#t0010){ref-type="table"} summarizes our results. Exploratory analyses did not reveal any significant main or interactive effects of psychotropic medications, percent lifetime spent ill, prior exposure to lithium or history of psychosis on anisotropy or diffusivity measures.

4. Discussion {#s0050}
=============

To our knowledge, this is one of the first studies to examine whole brain WM microstructure in bipolar adults who were all euthymic and lithium free at the time of the scan. Relative to healthy controls, bipolar patients showed pervasive aberrations in several major inter-and intra-hemispheric tracts, including the CC, frontal WM, limbic and projection fibers. These findings are consistent with a growing literature implicating WM abnormalities in BD ([@bb0345; @bb0135; @bb0165; @bb0170]) and in healthy individuals at high genetic risk for BD ([@bb0350; @bb0160]), suggesting that the WM pathology that we have observed here may precede the onset of BD. Our study builds upon prior research of microstructural WM deficits in BD, through demonstrating patterns of WM abnormalities in a BD sample that was carefully recruited to control for mood state and current lithium treatment. Moreover, our study suggests WM alterations in regions not previously reported as having associations with the disease (e.g., the fornix and ST), as well as a region with only one previous report of involvement (e.g., the *tapetum*).

A unique finding in our study was that of increased RD and MD in patients relative to healthy controls in the bilateral fornix and ST, and of decreased FA in the right ST. The fornix is central to the limbic system and contains pathways to the hypothalamus, thalamus, hippocampus, and *nucleus accumbens*, regions important for memory, emotional regulation and reward processing, which have been implicated in BD ([@bb0355; @bb0360]). The ST connects the amygdala and hippocampus ([@bb0365]), which plays an important role in episodic representations of emotionally significant memories ([@bb0370]). There is only one DTI study that, consistent with our results, found significantly lower FA in the fornix in adolescent BD ([@bb0085]), but these findings did not extend to diffusivity measures. The fornix and ST are very thin structures, and we cannot rule out partial volume effects accounting for some of these findings, despite correcting for multiple comparisons. As a result, our findings in these regions should be interpreted with caution and warrant further study at higher spatial resolution.

Our findings of reduced FA and increased MD and RD of the CC in BD support the notion that inter-hemispheric communications have a key role in BD pathophysiology. This is consistent with several DTI studies of patients with or at high genetic risk of BD, including one recent study from our group of a non-overlapping bipolar cohort ([@bb0085; @bb0100; @bb0105; @bb0115; @bb0125; @bb0180; @bb0185; @bb0345; @bb0150; @bb0155; @bb0160; @bb0215; @bb0220]), but are in contrast with [@bb0195], who found *higher* FA in the *genu* of BD patients relative to healthy controls. The CC, which interconnects the hemispheres, is the largest commissural fiber bundle of the brain, and is critically involved in the integration of emotional, attentional, perceptual and cognitive functions that are frequently compromised in BD ([@bb0375]). Further, we extend previous CC findings by showing significantly decreased FA and increased MD and RD in the *tapetum*, a callosal tract that projects from the splenium to the temporal lobes, which has only once been previously implicated in BD, among first episode patients experiencing psychosis ([@bb0380]).

The patterns of lower FA and higher MD and RD in association fibers that we observed in BD patients are consistent with a number of previous BD studies ([@bb0095; @bb0100; @bb0105; @bb0115; @bb0125; @bb0190; @bb0135; @bb0160; @bb0170]). Associative tracts implicated in our study are the SFOF, which is important for spatial awareness and symmetrical processing ([@bb0385]), the IFOF, which connects the orbito-frontal cortex with the occipital lobe ([@bb0390]), the SLF, which connects the frontal lobe with parieto-temporal regions essential for working memory processing ([@bb0395; @bb0400; @bb0045; @bb0405]) and the ILF, which connects the anterior temporal lobe and amygdala with the occipital cortex, and supports visual processing of emotionally salient information ([@bb0410; @bb0415]). Disrupted WM microarchitecture in these regions may relate to disturbances in executive function observed in individuals with BD ([@bb0075; @bb0420]), such as poor judgment and impaired decision-making capacity ([@bb0130; @bb0425]). Further, in addition to the cognitive functions subserved by the SLF and ILF mentioned above, these tracts also work to integrate auditory and speech areas of the brain ([@bb0410; @bb0135]); disruptions in the WM microstructure of these areas may thus contribute to speech-related symptoms that are observed in BD ([@bb0135]). The ILF and IFOF have been implicated elsewhere as critical to the processing of facial emotion ([@bb0430]). Difficulties in the ability to correctly identify facial emotions have been proposed as a potential endophenotype for BD ([@bb0435; @bb0440]); structural anomalies in the ILF and IFOF of BD individuals may contribute to such a deficit. Additionally, decreased WM density in the bilateral SLF has been shown to be associated with the genetic risk for developing BD ([@bb0445]). Our findings of disrupted WM microstructure in the SLF may contribute to the further study of whether genetic risk for developing BD could be associated with some of the reported brain abnormalities in this illness.

Lower FA and increased MD and RD were also found in patients relative to healthy controls in the cingulum bundle, specifically in fibers connecting to the hippocampus. This finding is consistent with many bipolar DTI studies of the cingulum ([@bb0085; @bb0105; @bb0120; @bb0135; @bb0215]). As the hippocampus is implicated in memory consolidation and spatial navigation ([@bb0450; @bb0455]), disruptions in the WM tracts that connect this region to other parts of the brain may contribute to declarative memory impairments ([@bb0460; @bb0465; @bb0470]), or to impairments in episodic memory and spatial span performance ([@bb0360]) in BD.

Finally, we observed group differences in WM structure within the projection fibers of the *corona radiata*, internal capsule, cerebral peduncle and the PTR. The *corona radiata* is a band of fibers projecting to and from the cerebral cortex that converges near the brainstem to form the internal capsule, and inferiorly, the cerebral peduncles. The ALIC contains the thalamic radiations, while the PLIC and cerebral peduncles encompass the corticobulbar, corticopontine, and corticospinal tracts, which are responsible for initiating and controlling movements. The PTR includes the optic radiation, which connects the thalamus and the occipital lobe; disruption to this tract may affect visual processing, which was found to be impaired in some BD patients in a study by [@bb0475]. While diffusivity measures were increased in the internal capsule, there were no accompanying FA differences. In contrast, FA was lower in the left cerebral peduncle, with no detected differences in diffusivity. Similarly, while FA was lower in the *corona radiata*, there were no MD differences. The PTR showed both decreased FA and increased RD and MD, which could be representative of compromised myelin and axonal integrity. Our findings in these areas are consistent with prior studies which have found reduced FA in the projection fibers of bipolar patients ([@bb0085; @bb0100; @bb0110; @bb0190; @bb0145; @bb0150; @bb0165]) and those at high genetic risk for BD ([@bb0350; @bb0160]) compared to controls, and may relate to deficits in motor inhibition and cognitive function in BD ([@bb0480; @bb0070]), resulting in inappropriate modulation of emotional responses, execution of tasks with disregard to past experiences, and an inability to predict the outcomes of their actions ([@bb0190; @bb0485]).

A recent study evaluating a non-overlapping cohort, with unrelated scan acquisition parameters ([@bb0490]) examined the fiber density of various tracts using tractography. In that study, significant differences between bipolar and control subjects were found in tract length and tract density, but no FA differences were detected in some of the regions reported here, except for a FA difference in the cerebrospinal tract. Cohort differences may account for this, as the samples were non-overlapping and were scanned at different field strengths. Also, both cohorts are relatively small and are only powered to find moderate but not small effect sizes. Thus, small effects may have been present but not detected in both studies. Further, our current voxel-based analyses survey the whole WM and map based methods do pick up patterns that ROI based methods may not, and vice versa. This also may affect the sensitivity to pick up group differences throughout the brain. As many studies are barely powered to detect subtle and distributed disease effects, we are making a serious effort to harmonize future neuroimaging studies of bipolar disorder to avoid this dilemma where differences in results may reflect cohort differences or protocol differences. Our ENIGMA bipolar working group ([@bb0495]) pools MRI data from 9 sites (with more being added), allowing us to use meta-analysis to home in on the most consistent results.

Our findings should be interpreted with several limitations in mind. First, while we have noted some drawbacks of ROI and TBSS based methods, voxel based approaches also have some limitations. For example, the smoothing kernel size can influence study findings ([@bb0500]), and it needs to be set in advance, often without *a priori* information about the spatial extent of the effects of interest, which also may vary from one brain region to another. When voxel-based maps are smoothed, images are blurred to maximize the power to detect spatially coherent effects, and to minimize the impact of misalignment error and anatomical differences across subjects, which inevitably leads to some loss of spatial resolution and decreased sensitivity for detecting abnormalities in small structures or in areas of high anatomic variability. Even so, these are also limitations for the ROI method, which is effectively the same as applying a large uniform filter to a selected region. In voxel-based methods, some findings close to CSF borders can reflect structural differences rather than purely microstructural changes, but most of the voxels we report in this study were far from CSF. It can also be challenging to ensure that each voxel contains only data from the same part of the same WM tract in all subjects due to alignment inaccuracies ([@bb0505]). Voxel based methods have been criticized as being susceptible to 'edge effects' caused by misregistration of tracts ([@bb0510]), especially in regions where the FA changes sharply at an interface. As with any voxelwise analysis there is an increased risk of losing power by making a heavy correction for multiple comparisons, although we decreased this risk by restricting the analysis to WM only with a WM mask. Second, while we avoided the confounding effects of lithium in our WM measurements by recruiting only lithium-free patients, 16 bipolar subjects were taking one or more other psychotropic medications, whose effects on WM structure are unknown. However, exploratory analyses did not reveal significant effects of psychotropic medications on anisotropy or diffusivity measures, and previous studies conducted in bipolar ([@bb0115; @bb0515]) and schizophrenic ([@bb0520; @bb0525]) populations failed to find significant effects of medication on diffusion measures as well. Third, there is some concern that substance use may have contributed to the detected effects on the brain. We have explored this further by calculating and plotting the mean FA values of the bipolar and control groups in the CC. The mean FA values for the bipolar subjects with a history of drug abuse or dependence were found to be distributed fairly evenly among the group\'s values, with no obvious pattern between subjects who were substance naïve versus those who had previous exposure. This is shown in [Fig. 4](#f0020){ref-type="fig"}, where the FA values (in red) belonging to the bipolar subjects who had a history of drug abuse or dependence are indicated with a purple border, for easier visualization. Fourth, the sample size, while consistent with other published studies, was limited. Our future studies should be able to increase the number of subjects by establishing consortium efforts ([@bb9000]; [@bb0495; @bb0530]) to investigate larger groups of patients with and without lithium exposure. Lastly, the current study used 30-direction DWI, which is common in clinical settings, but does not have high angular resolution. This number of directions does not allow us to determine whether the FA, MD and RD differences observed here were the result of a group difference in the number or relative density of crossing fibers. Higher spatial resolution may also allow us to better distinguish smaller brain structures such as the *stria terminalis* and fornix. Future studies with more diffusion-weighted gradients could assess this, at the expense of longer scan times. Future studies may also benefit from the use of DTI tractography, which can reconstruct white matter pathways in vivo, offering information on anatomical connectivity between distant brain areas ([@bb0345]).

In conclusion, in a sample of euthymic, lithium-free BD patients, we found widespread abnormalities in the integrity of WM tracts connecting brain regions critically involved in regulating behavior, cognition and emotion. Future studies that examine the direct association between WM abnormalities and behavior in BD are of interest, and may assist in understanding symptoms and prognosis for patients with BD.
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![Fractional anisotropy differences in bipolar patients vs. controls. a. White matter regions where fractional anisotropy (FA) was significantly lower in bipolar patients compared to healthy controls. *p*-values have been corrected with searchlight FDR. b. Regression coefficients in white matter regions where voxels differed significantly between groups. Units are in FA unit difference between groups. PTR---posterior thalamic radiation; PCR---posterior corona radiata, SCR---superior corona radiata; SLF---superior longitudinal fasciculus; ILF---inferior longitudinal fasciculus; IFOF---inferior fronto-occipital fasciculus; CC---corpus callosum; L---left; R---right.](gr1){#f0005}

![Mean diffusivity differences in bipolar patients vs. controls. a. White matter regions where mean diffusivity (MD) was significantly higher in bipolar patients compared to healthy controls. *p*-values have been corrected with searchlight FDR. b. Regression coefficients in white matter regions where voxels differed significantly between groups. Units are in MD unit difference between groups. ALIC---anterior limb of internal capsule; PLIC---posterior limb of internal capsule; RLIC---retrolenticular limb of internal capsule; PTR---posterior thalamic radiation; SLF---superior longitudinal fasciculus; ILF---inferior longitudinal fasciculus; IFOF---inferior fronto-occipital fasciculus; CC---corpus callosum; ST---stria terminalis; L---left; R---right; \*---DTI resolution precludes resolving with anatomical certainty.](gr2){#f0010}

![Radial diffusivity differences in bipolar patients vs. controls. a. White matter regions where radial diffusivity (RD) was significantly higher in bipolar patients compared to healthy controls. *p*-values have been corrected with searchlight FDR. b. Regression coefficients in white matter regions where voxels differed significantly between groups. Units are in RD unit difference between groups. ALIC---anterior limb of internal capsule; PLIC---posterior limb of internal capsule; RLIC---retrolenticular limb of internal capsule; PTR---posterior thalamic radiation; PCR---posterior corona radiata, SCR---superior corona radiata; SLF---superior longitudinal fasciculus; ILF---inferior longitudinal fasciculus; IFOF---inferior fronto-occipital fasciculus; SFOF---superior fronto-occipital fasciculus; CC---corpus callosum; ST---stria terminalis; L---left; R---right; \*---DTI resolution precludes resolving with anatomical certainty.](gr3){#f0015}

![Mean FA values in the corpus callosum, for each subject, are plotted by diagnostic group. Control FA values are shown in blue and bipolar FA values are shown in red. Values for subjects who had a history of drug abuse or dependence are outlined in purple.](gr4){#f0020}

###### 

Subject demographics.

  Demographic variable                               Patients with bipolar disorder (n = 23)   Normal controls (n = 19)   Group difference
  -------------------------------------------------- ----------------------------------------- -------------------------- ------------------
  Age (mean ± SD)                                    36.0 ± 12.5                               36.2 ± 12.4                *p* = 0.98
  \% female (n)                                      30.4 (7)                                  31.6 (6)                   *p* = 0.94
  Years of education                                 14.7 ± 1.8                                15.6 ± 1.8                 *p* = 0.09
  \% right handed                                    100 (23)                                  100 (19)                   *p* = 1.00
  HAMD[a](#tf0005){ref-type="table-fn"}              4.7 ± 2.2                                 1.2 ± 1.4                  *p* \< 0.001
  YMRS[b](#tf0010){ref-type="table-fn"}              1.7 ± 2.2                                 0.5 ± 1.5                  *p* = 0.04
  Duration of illness (years)                        18.7 ± 12.1                               --                         --
  Age at onset                                       17.3 ± 7.6                                --                         --
  Prior manias                                       13.0 ± 27.7                               --                         --
  Prior depressions                                  10.8 ± 20.4                               --                         --
  Prior hospitalizations for mania                   1.6 ± 1.7                                 --                         --
  Prior hospitalizations for depression              0.8 ± 1.2                                 --                         --
  Months euthymic[c](#tf0015){ref-type="table-fn"}   13.0 ± 16.0                               --                         --

All *p*-values show two-tailed significance levels.

Hamilton Depression Rating Scale.

Young Mania Rating Scale.

Indicates time euthymic prior to scanning.

###### 

Summary of findings.

  ------------------------------------------------------------------------------------------
  Areas of significant group differences         FA\           MD\            RD\
                                                 lower in BD   higher in BD   higher in BD
  ---------------------------------------------- ------------- -------------- --------------
  Corpus callosum---*genu*                       Significant   No sig diff    No sig diff

  Corpus callosum---body, splenium               Significant   Significant    Significant

  *Tapetum*                                      Bilateral     No sig diff    Bilateral

  Superior longitudinal fasciculus               Bilateral     Bilateral      Bilateral

  Inferior longitudinal fasciculus               Bilateral     Bilateral      Bilateral

  Inferior fronto-occipital fasciculus           Bilateral     Bilateral      Bilateral

  Superior fronto-occipital fasciculus           No sig diff   Bilateral      Bilateral

  Cingulum---hippocampus                         Left          Bilateral      Bilateral

  Fornix                                         Significant   Significant    Significant

  *Stria terminalis*                             Right         Bilateral      Bilateral

  Posterior thalamic radiation/optic radiation   Bilateral     Bilateral      Bilateral

  *Corona radiata*---superior                    Right         No sig diff    Bilateral

  *Corona radiata*---posterior                   Bilateral     No sig diff    Right

  *Corona radiata*---anterior                    Right         No sig diff    No sig diff

  Internal capsule---anterior                    No sig diff   Bilateral      Bilateral

  Internal capsule---posterior                   No sig diff   Bilateral      Bilateral

  Internal capsule---retrolenticular             No sig diff   Right          Right

  Cerebral peduncle                              Left          No sig diff    No sig diff
  ------------------------------------------------------------------------------------------
